SEC Form 4 · accession 0001140361-18-011285
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Business Operations
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 27, 2018 | A | 5,036 | $0.00 | A | 31,082 | D | |
| Common StockF3 | Feb 27, 2018 | A | 5,036 | $0.00 | A | 36,118 | D | |
| Common StockF1 | Feb 27, 2018 | F | 409 | $49.64 | D | 35,709 | D | |
| Common StockF1 | Feb 28, 2018 | F | 811 | $49.97 | D | 34,898 | D | |
| Common StockF5 | Mar 1, 2018 | S | 1,898 | $49.50 | D | 33,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buyF4 | $49.64 | Feb 27, 2018 | A | 20,145 | A | — | Feb 26, 2025 | Common Stock | 20,145 | 20,145 | D |
Explanation of responses
- F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- F2These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- F3Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period.
- F4Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021.
- F5This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.